A leader in the field of lung imaging. Polarean (AIM: POLX) has successfully developed the first and only FDA approved hyperpolarized MRI contrast agent.

ID: 1220222620366446592

linkhttp://www.polarean.com calendar_today23-01-2020 05:52:06